VTE Prevention Following Total Hip and Knee Arthroplasty

NCT04075240 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

5400

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Rivaroxaban 10 MG and acetylsalicylic acid 81 mg
DRUG: acetylsalicylic acid 81 mg

Sponsor

Sudeep Shivakumar

Collaborators

[object Object]
[object Object]
[object Object]